Should I do chemotherapy before or after surgery for Inflammatory Breast Cancer

Chemotherapy Timing for Inflammatory Breast Cancer

This is an excellent and important question. The answer is clear based on current medical evidence: for inflammatory breast cancer (IBC), chemotherapy should come BEFORE surgery, not after.

Why Chemotherapy First? (The Clinical Reasoning)

According to the NCCN Guidelines for Patients: Inflammatory Breast Cancer, the standard approach is called preoperative systemic therapy (also called neoadjuvant therapy). Here's why oncologists recommend this sequence:

The Goals:

• Shrink the tumor so it becomes small enough to remove surgically
• Assess how your cancer responds to treatment—this information is crucial for planning what happens after surgery
• Improve surgical outcomes by reducing the cancer burden before the operation
• Determine what additional treatment you'll need based on how well the cancer responds

How This Works in Practice

Step 1: Chemotherapy First You'll receive systemic therapy (chemotherapy and/or targeted drugs) before surgery. The specific drugs depend on your tumor's biomarkers:

• If your cancer is HER2-positive, you'll receive HER2-targeted therapy
• If your cancer is hormone receptor-positive (ER+ or PR+), you may receive additional hormone therapy later
• Your care team will assess your response with physical exams and imaging tests during treatment

Step 2: Surgery (If Possible) After chemotherapy, your doctors will evaluate whether surgery is feasible:

• If the tumor has shrunk enough, you'll have a total mastectomy with lymph node removal (lumpectomy is not typically an option for IBC because it usually involves a large portion of the breast)
• You may also plan for delayed breast reconstruction if desired

Step 3: Additional Treatment After Surgery After surgery, you'll likely receive:

• Radiation therapy (an important part of IBC treatment)
• Additional chemotherapy if you didn't complete all cycles before surgery
• Continued targeted therapy (HER2-targeted therapy for up to one year if your cancer is HER2+)
• Hormone therapy if your cancer is hormone receptor-positive

What If Surgery Isn't Possible?

According to the NCCN Guidelines, even if surgery becomes impossible after chemotherapy, treatment continues. Your care team may consider radiation therapy to try to shrink the cancer further, or continue systemic therapy. The goal remains to reduce the cancer burden and manage your disease.

Key Questions to Ask Your Oncology Team

To make sure you understand YOUR specific plan:

1. "Based on my tumor's biomarkers (HER2 status, hormone receptor status), what chemotherapy regimen do you recommend, and why?"

2. "How will we assess whether the chemotherapy is working, and how often will we check?"

3. "What is the timeline—how long will chemotherapy last before we consider surgery?"

4. "If the tumor doesn't shrink enough for surgery, what are our next options?"

5. "What will my treatment look like after surgery, and for how long?"

6. "Are there clinical trials I might be eligible for that could offer additional options?"

Important Context

The NCCN Guidelines emphasize that preoperative systemic therapy is the standard approach for IBC. This differs from some other breast cancers where surgery might come first. IBC is aggressive and typically involves multiple areas of the breast, which is why the chemotherapy-first approach has become the established standard of care.

Your oncologist will determine the most appropriate approach for YOUR specific case based on your complete clinical picture, including your overall health, tumor characteristics, and personal preferences.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.